Company Filing History:
Years Active: 2023-2024
Title: Sandra Weil: Innovator in Biopharmaceuticals
Introduction
Sandra Weil is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative antibodies and binding proteins. With a total of three patents to her name, her work has the potential to impact the treatment of various diseases.
Latest Patents
Sandra's latest patents include a humanized anti-IL-1R3 antibody and methods of use. This antibody specifically binds to IL-1R3 and comprises an antibody heavy chain amino acid sequence of SEQ ID NO: 1 and a light chain amino acid sequence of SEQ ID NO: 2. The patent also describes a pharmaceutical composition that includes this antibody along with a pharmaceutically acceptable diluent, carrier, or excipient. This antibody is intended for use in treating autoimmune or autoinflammatory diseases. Another notable patent involves multispecific binding proteins with mutant fab domains. These binding proteins consist of a VL region paired with a VH region, and a CH1 region paired with a CL region, featuring engineered mutations to facilitate pairing. This patent also covers binding proteins with cysteine residues engineered into the VH/VL pair to form disulfide bonds, along with related nucleic acids, expression vectors, and methods of treatment.
Career Highlights
Throughout her career, Sandra has worked with leading companies in the biopharmaceutical industry, including Sanofi and Sanofi Biotechnology. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.
Collaborations
Sandra has collaborated with notable professionals in her field, including Christian Lange and Christian Beil. These partnerships have further enhanced her research and development efforts, leading to groundbreaking innovations.
Conclusion
Sandra Weil is a trailblazer in the biopharmaceutical sector, with her patents paving the way for new treatments for autoimmune and autoinflammatory diseases. Her work exemplifies the impact of innovation in healthcare, showcasing the importance of research and collaboration in advancing medical science.